98 related articles for article (PubMed ID: 18330902)
21. The EWS-ATF-1 gene involved in malignant melanoma of soft parts with t(12;22) chromosome translocation, encodes a constitutive transcriptional activator.
Fujimura Y; Ohno T; Siddique H; Lee L; Rao VN; Reddy ES
Oncogene; 1996 Jan; 12(1):159-67. PubMed ID: 8552387
[TBL] [Abstract][Full Text] [Related]
22. The N-terminal domain of human TAFII68 displays transactivation and oncogenic properties.
Bertolotti A; Bell B; Tora L
Oncogene; 1999 Dec; 18(56):8000-10. PubMed ID: 10637511
[TBL] [Abstract][Full Text] [Related]
23. Skeletal and extraskeletal myxoid chondrosarcoma: related or distinct tumors?
Rubin BP; Fletcher JA
Adv Anat Pathol; 1999 Jul; 6(4):204-12. PubMed ID: 10410173
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic utility of molecular investigation in extraskeletal myxoid chondrosarcoma.
Benini S; Cocchi S; Gamberi G; Magagnoli G; Vogel D; Ghinelli C; Righi A; Picci P; Alberghini M; Gambarotti M
J Mol Diagn; 2014 May; 16(3):314-23. PubMed ID: 24508382
[TBL] [Abstract][Full Text] [Related]
25. Transactivation of cyclin E gene by EWS-Fli1 and antitumor effects of cyclin dependent kinase inhibitor on Ewing's family tumor cells.
Li X; Tanaka K; Nakatani F; Matsunobu T; Sakimura R; Hanada M; Okada T; Nakamura T; Iwamoto Y
Int J Cancer; 2005 Sep; 116(3):385-94. PubMed ID: 15818598
[TBL] [Abstract][Full Text] [Related]
26. Localization of TEC to 9q22.3-q31 by fluorescence in situ hybridization.
Kleinfinger P; Labelle Y; Melot T; Thomas G; Delattre O; Aurias A
Ann Genet; 1996; 39(4):233-5. PubMed ID: 9037350
[TBL] [Abstract][Full Text] [Related]
27. EWS-Oct-4B, an alternative EWS-Oct-4 fusion gene, is a potent oncogene linked to human epithelial tumours.
Kim S; Lim B; Kim J
Br J Cancer; 2010 Jan; 102(2):436-46. PubMed ID: 20051954
[TBL] [Abstract][Full Text] [Related]
28. A role of the TATA box and the general co-activator hTAF(II)130/135 in promoter-specific trans-activation by simian virus 40 small t antigen.
Johannessen M; Olsen PA; Sørensen R; Johansen B; Seternes OM; Moens U
J Gen Virol; 2003 Jul; 84(Pt 7):1887-1897. PubMed ID: 12810884
[TBL] [Abstract][Full Text] [Related]
29. Extraskeletal myxoid chondrosarcoma: a clinicopathologic, immunohistochemical, and molecular analysis of 18 cases.
Okamoto S; Hisaoka M; Ishida T; Imamura T; Kanda H; Shimajiri S; Hashimoto H
Hum Pathol; 2001 Oct; 32(10):1116-24. PubMed ID: 11679947
[TBL] [Abstract][Full Text] [Related]
30. Identification of various exon combinations of the ews/fli1 translocation: an optimized RT-PCR method for paraffin embedded tissue -- a report by the CWS-study group.
Stegmaier S; Leuschner I; Aakcha-Rudel E; Münch P; Kazanowska B; Bekassy A; Treuner J; Koscielniak E
Klin Padiatr; 2004; 216(6):315-22. PubMed ID: 15565546
[TBL] [Abstract][Full Text] [Related]
31. The oncogenic fusion protein EWS/NOR-1 induces transformation of CFK2 chondrogenic cells.
Filion C; Labelle Y
Exp Cell Res; 2004 Jul; 297(2):585-92. PubMed ID: 15212958
[TBL] [Abstract][Full Text] [Related]
32. Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI-1 fusion gene.
Lessnick SL; Braun BS; Denny CT; May WA
Oncogene; 1995 Feb; 10(3):423-31. PubMed ID: 7845667
[TBL] [Abstract][Full Text] [Related]
33. An in vitro enzymatic assay coupled to proteomics analysis reveals a new DNA processing activity for Ewing sarcoma and TAF(II)68 proteins.
Guipaud O; Guillonneau F; Labas V; Praseuth D; Rossier J; Lopez B; Bertrand P
Proteomics; 2006 Nov; 6(22):5962-72. PubMed ID: 17106916
[TBL] [Abstract][Full Text] [Related]
34. TFG is a novel fusion partner of NOR1 in extraskeletal myxoid chondrosarcoma.
Hisaoka M; Ishida T; Imamura T; Hashimoto H
Genes Chromosomes Cancer; 2004 Aug; 40(4):325-8. PubMed ID: 15188455
[TBL] [Abstract][Full Text] [Related]
35. Oncogenic EWS-Fli1 interacts with hsRPB7, a subunit of human RNA polymerase II.
Petermann R; Mossier BM; Aryee DN; Khazak V; Golemis EA; Kovar H
Oncogene; 1998 Aug; 17(5):603-10. PubMed ID: 9704926
[TBL] [Abstract][Full Text] [Related]
36. EWS/Fli-1 chimeric protein is a transcriptional activator.
Ohno T; Rao VN; Reddy ES
Cancer Res; 1993 Dec; 53(24):5859-63. PubMed ID: 7503813
[TBL] [Abstract][Full Text] [Related]
37. The DNA binding domains of the WT1 tumor suppressor gene product and chimeric EWS/WT1 oncoprotein are functionally distinct.
Kim J; Lee K; Pelletier J
Oncogene; 1998 Feb; 16(8):1021-30. PubMed ID: 9519876
[TBL] [Abstract][Full Text] [Related]
38. Studies on the molecular pathogenesis of extraskeletal myxoid chondrosarcoma-cytogenetic, molecular genetic, and cDNA microarray analyses.
Sjögren H; Meis-Kindblom JM; Orndal C; Bergh P; Ptaszynski K; Aman P; Kindblom LG; Stenman G
Am J Pathol; 2003 Mar; 162(3):781-92. PubMed ID: 12598313
[TBL] [Abstract][Full Text] [Related]
39. Coexpression of NOR1 and SIX3 proteins in extraskeletal myxoid chondrosarcomas without detectable NR4A3 fusion genes.
Hisaoka M; Okamoto S; Yokoyama K; Hashimoto H
Cancer Genet Cytogenet; 2004 Jul; 152(2):101-7. PubMed ID: 15262426
[TBL] [Abstract][Full Text] [Related]
40. t(9;22)(q22-31;q11-12) is a consistent marker of extraskeletal myxoid chondrosarcoma: evaluation of three cases.
Sciot R; Dal Cin P; Fletcher C; Samson I; Smith M; De Vos R; Van Damme B; Van den Berghe H
Mod Pathol; 1995 Sep; 8(7):765-8. PubMed ID: 8539235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
